Machine Learning for Reclassification of Obesity

June 23, 2020 updated by: Shen Qu, Shanghai 10th People's Hospital

Data-driven Clustering for Metabolic Classification of Obesity Using Machine Learning

The goal of this study is to employ or develop computational modeling techniques for the precise reclassification of obesity into subgroups. Clinical features, risks of noncommunicable diseases, as well as weight loss effects of bariatric surgery will also be studied and compared within the subgroups.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

2495

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200072
        • Shanghai Tenth People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with overweight/obesity.

Description

Inclusion Criteria:

  1. Patients with overweight/obesity
  2. Patients with normal weight as controls

Exclusion Criteria:

  1. had ever been performed with a bariatric surgery before the study's first visit is scheduled;
  2. had taken exogenous insulin, medication that affects glucose metabolism, or uric acid drugs currently;
  3. being diagnosed with type 1 diabetes, secondary diabetes, hereditary disease, or severe disease (e.g. malignant tumor, heart failure, liver failure, etc.);
  4. in gestation of lactation;
  5. did not have the complete data for model;
  6. for normal-weight controls, patients with diabetes or hyperuricemia were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
NW
normal weight control
MHO
metabolic healthy obesity
Computational modeling techniques will be used for the precise reclassification of obesity into four subgroups, several variables according to the clinical experience and the modeling results will be selected for the cluster analysis.
LMO
hypometabolic obesity
Computational modeling techniques will be used for the precise reclassification of obesity into four subgroups, several variables according to the clinical experience and the modeling results will be selected for the cluster analysis.
HMO-U
hypermetabolic obesity with hyperuricemia
Computational modeling techniques will be used for the precise reclassification of obesity into four subgroups, several variables according to the clinical experience and the modeling results will be selected for the cluster analysis.
HMO-I
hypermetabolic obesity with hyperinsulinemia
Computational modeling techniques will be used for the precise reclassification of obesity into four subgroups, several variables according to the clinical experience and the modeling results will be selected for the cluster analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Metabolic classification of patients with obesity using machine learning
Time Frame: baseline
baseline

Secondary Outcome Measures

Outcome Measure
Time Frame
Metabolic features in patients of different subgroups
Time Frame: baseline
baseline
Risks for noncommunicable disease in patients of different subgroups
Time Frame: baseline
baseline
Effect of bariatric surgery in patients of different subgroups
Time Frame: 1 year after bariatric surgery
1 year after bariatric surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

April 30, 2020

Study Completion (Actual)

June 20, 2020

Study Registration Dates

First Submitted

February 21, 2020

First Submitted That Met QC Criteria

February 21, 2020

First Posted (Actual)

February 25, 2020

Study Record Updates

Last Update Posted (Actual)

June 25, 2020

Last Update Submitted That Met QC Criteria

June 23, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Obesity Reclassification

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on AI classification of patients with obesity

Subscribe